**Executive Summary**
The National Pharmaceutical Pricing Authority (NPPA) has issued a notification to revise the ceiling prices for coronary stents based on a Wholesale Price Index (WPI) increase of 0.64956% for the year 2025. These revised prices apply to Bare Metal Stents and Drug Eluting Stents, effective from April 1, 2026. Manufacturers, importers, and retailers must comply with these price caps and display requirements to avoid penalties under the Essential Commodities Act, 1955.
**Key Points / Main Content**
**Revised Ceiling Prices**
* **Bare Metal Stents:** The ceiling price is fixed at ₹10,762.15 per unit.
* **Drug Eluting Stents (DES):** The ceiling price is fixed at ₹39,186.03 per unit, which includes metallic DES and Bioresorbable Vascular Scaffold (BVS)/Biodegradable Stents.
* **Taxation:** The specified ceiling prices are exclusive of Goods and Services Tax (GST).
**Pricing Rules and Adjustments**
* **WPI Basis:** The revision is based on a WPI of 0.64956% for the year 2025 over 2024.
* **MRP Revision:** Manufacturers or importers with an existing Maximum Retail Price (MRP) lower than the new ceiling price may revise their prices based on the 0.64956% WPI increase.
* **GST Application:** Manufacturers and importers may only add GST to the ceiling price if the tax has actually been paid or is payable to the government.
**Compliance and Disclosure**
* **Public Display:** Retailers and dealers are required to display the price list and any supplementary price lists in a conspicuous, easily accessible location within their business premises.
* **Legal Enforcement:** Failure to comply with the ceiling prices or the associated notes will render the manufacturer liable for depositing the overcharged amount plus interest under the Drugs (Prices Control) Order, 2013, and the Essential Commodities Act, 1955.
**Impact Analysis**
**Manufacturers and Importers**
**Impact**
They are restricted from charging beyond the revised ceiling prices and must adjust their commercial pricing structures to align with the 0.64956% WPI increase.
**Action Required**
Revise existing MRPs where necessary and ensure that any added GST reflects actual payments made to the government.
**Retailers and Dealers**
**Impact**
They are responsible for ensuring price transparency at the point of sale.
**Action Required**
Prominently display the updated price lists and supplementary lists provided by manufacturers in their place of business for public consultation.
**National Pharmaceutical Pricing Authority (NPPA)**
**Impact**
The authority acts as the monitoring body to ensure the affordability of coronary stents.
**Action Required**
Enforce the revised rates and initiate recovery proceedings (including interest) against entities found to be overcharging consumers.
Key Entities Referenced
National Pharmaceutical Pricing Authority (NPPA): The regulatory body under the Ministry of Chemicals and Fertilizers responsible for fixing and revising the ceiling prices of medical devices and drugs.
Drugs (Prices Control) Order, 2013 (DPCO, 2013): The primary regulatory framework used to monitor and control the prices of essential medicines and medical devices in India.
Essential Commodities Act, 1955: The overarching legislation that provides the legal basis for price control and enforcement of the DPCO.
Coronary Stents: The specific category of medical devices, including Bare Metal and Drug Eluting Stents, whose ceiling prices are revised in this notification.
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99
सी.जी.-डी.एल.-अ.-25032026-271288
CG-DxLx-xEG-I2D5H0x3x2x0 26-271288
xxxGIDExxx
असाधारण
EXTRAORDINARY
भाग II—खण् ड 3—उप-खण्ड (ii)
PART II—Section 3—Sub-section (ii)
प्राजधकार स ेप्रकाजित
PUBLISHED BY AUTHORITY
स.ं 1522] नई दिल्ली, बधु िार, मार् च25, 2026/र्त्रै 4, 1948 13, 1947 26/पौष 17, 1947
No. 1522] NEW DELHI, WEDNESDAY, MARCH 25, 2026/CHAITRA 4, 1948 ss, 1947 /PAUSHA 17, 1947
रसायन और उर्रव क मत्रं ालय
(औषध वर्भाग)
(राष्ट्रीय औषध मल्ू य वनधारव ण प्रावधकरण)
आदेश
नई दिल्ली, 25 मार्च, 2026
का.आ. 1587(अ).— राष्ट्रीय औषध मूल्य जनधाचरण प्राजधकरण, औषध जिभाग, रसायन एि ं उिचरक मंत्रालय द्वारा
कोरोनरी स्ट्टेंट्स के अजधकतम मूल्य जनधाचरण के संबंध म ें िारी अजधसूर्नाओं का.आ. 639(अ) दिनांक 12.02.2018,
1464(अ) दिनांक 02.04.2018, 1488(अ) दिनांक 29.03.2019, 1217(अ) दिनांक 25.03.2020, 1334(अ) दिनांक
25.03.2021, 1502(अ) दिनांक 30.03.2022, 5249(अ) दिनांक 11.11.2022, 1572(अ) दिनांक 31.03.2023,
4663(अ) दिनांक 25.10.2023, 1551(अ) दिनांक 26.03.2024, 1605(अ) दिनांक 03.04.2024 और 1473(अ) दिनाकं
27.03.2025 में उस सारणी के स्ट्तंभ (4) में जिजनर्िचष्ट अजधकतम कीमत के संबंध में यह जनणचय जलया गया ह ै दक र्षव 2024
की अपेक्षा र्षव 2025 के जलए @0.64956% की िर स ेथोक मूल्य सूर्कांक (डब्लल्यूपीआई) पर जिर्ार करन ेके बाि एतद्द्वारा
कोरोनरी स्ट्टेंट्स के िर्णचत अजधकतम मूल्यो, िस्ट्तु एिं सेिा कर, यदि कोई ह,ै को छोड़कर, इस सारणी के स्ट्तंभ (4) म ेंजिजनर्िचष्ट
अजधकतम कीमत, स्ट्तंभ (3) में िर्णचत इकाई के मद्देनिर दिनाकं 1.4.2026 स ेजनम्न प्रकार स े संशोवधत दकया िाता हैःै
2204 GI/2026 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
सारणी
अजधकतम कीमत
(कोरोनरी स्ट्टेंट्स) इकाई (थोक मल्ू य सर्ू काकं सजहत 0.64956%
क्र.स.ं (डीपीसीओ, 2013 की अनसु र्ू ी- I म ेंक्र.स.ं28) (सख्ं या म)ें की िर स े1.4.2026 स ेप्रभािी (रुपय ेम)ें
(1) (2) (3) (4)
1 सािे धातु स्ट्टेंट 1 10762.15
2 औषध क्षालन स्ट्टेंट (डीईएस) जिसमें धाजविक डीईएस और
िैि अर्शोष्य िाजहका ढांर्ा (बीिीएस)/िैि अिक्रमणीय 1 39186.03
स्ट्टेंट सजममजलत हIैं
नोटैः.
(क) सभी मौिूिा जनमाचताओं/आयातकों को कोरोनरी स्ट्टेंट के अजधकतम खुिरा कीमत उपयक्तुच सारणी के स्ट्तंभ (4) म ें
वर्वनर्दवष्ट अजधकतम कीमत (िस्ट्तु एिं सेिा कर, यदि कोई ह)ै स ेकम ह,ै िहां कही भी लागू हो, औषध (मल्ू य जनयंत्रण) आदेश,
2013 के पैराग्राफ 13(2) के साथ पठित डीपीसीओ, 2013 के पैराग्राफ 16(2) के अनुसार र्षव 2024 की अपेक्षा र्षव 2025
के जलए @0.64956% की िर से थोक मूल्य सूर्कांक (डब्लल्यूपीआई) के आधार पर अपनी कोरोनरी स्ट्टेंट का मौिूिा अजधकतम
खुिरा मूल्य (एमआरपी) को सशं ोवधत कर सकते ह।ैं
(ख) अगर जनमाचताओं/आयातकों न े उपयुचक्त सारणी के स्ट्तंभ (4) म ें िर्णचत अजधकतम कीमत पर सरकार को िास्ट्ति म ें
भुगतान दकया ह ैया यह िेय ह ैतो िे िस्ट्त ु एिं सेिा कर को िोड़ सकत े ह।ै
(ग) औषध (मल्ू य जनयंत्रण) आदेश, 2013 के 24(4) के उपबंधों के अनुसार प्रवयेक फुटकर जिक्रेता और जितरक जिजनमाचता
द्वारा दिए गए रूप में ऐसे पठरसर, िहां कारोबार को इस प्रकार दकया िा रहा ह ैदक उससे परामशव के इच्छुक दकसी व्यजक्त के
जलए पहर्ं आसान हो, िहां उसके दकसी सहजदश्ृ य भाग पर कीमत सूर्ी और पूरक सूर्ी, यदि कोई हो, को संप्रदर्शतव करेगा।
(घ) जिजनमाचता/आयातक या जिपणन कमपनी, उपरोक्त कजथत सारणी में दशावय ेअजधकतम मल्ू य और शतों का पालन नहीं
करती ह ैं तो िे आर्श्यक िस्ट्तएु ँ अजधजनयम, 1955 के साथ पठित डीपीसीओ, 2013 के प्रािधानों के अधीन ब्लयाि सजहत
अजधप्रभाठरत रावश को िमा करने के जलए िायी होंगे।
[का.सं./276/144/2026/एफ़/फा.सं. 8(144)/2026/डीपी/एनपीपीए-जडिी-II]
भीिा राम यािि, सहायक जनििे क
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ORDER
New Delhi, the 25th March, 2026
S.O. 1587(E).— In continuation of the notifications issued by National Pharmaceutical Pricing Authority,
Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018, 1464(E) dated
02.04.2018, 1488(E) dated 29.03.2019, 1217(E) dated 25.03.2020, 1334(E) dated 25.03.2021, 1502(E) dated
30.03.2022, 5249(E) dated 11.11.2022, 1572(E) dated 31.03.2023, 4663(E) dated 25.10.2023, 1551(E) dated
26.03.2024, 1605(E) dated 03.04.2024 and 1473(E) dated 27.03.2025 regarding the fixation of ceiling price of the
Coronary Stents as specified in column no. (2) mentioned in the table below; after considering the Wholesale Price
Index (WPI) @ 0.64956% for the year 2025 over 2024, it has been decided to revise the ceiling prices of Coronary
Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit
specified in column (3) with effect from 01.04.2026, as under:[भाग II—खण् ड 3(ii)] भारत का रािपत्र : असाधारण 3
TABLE
Sl. Coronary Stents Unit Ceiling price
No. (w.e.f. 1.4.2026
(Sl. No. 28 in Schedule-I of the DPCO, 2013) (in
with WPI @ 0.64956%) (in Rs.)
Number)
(1) (2) (3) (4)
1 Bare Metal Stents 1 10762.15
Drug Eluting Stents (DES) including metallic DES
2 and Bioresorbable Vascular Scaffold (BVS)/ 1 39186.03
Biodegradable Stents
Notes: -
(a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified
in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing
MRP of Coronary Stent, on the basis of WPI @ 0.64956% for the year 2025 over 2024 in accordance with
Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013.
(b) The manufacturers/ importers of Coronary Stents may add Goods and Services Taxes only if they have paid
actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid
table.
(c) As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price
list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries
on business in a manner so as to be easily accessible to any person wishing to consult the same.
(d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to
deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control)
Order, 2013 read with Essential Commodities Act, 1955.
[PN/276/144/2026/F/F. No. 8(144)/2026/D.P./NPPA-Div.-II]
BHIVA RAM YADAV, Assistant Director
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.